CANF Forecast and Technical Stock Analysis
Buy candidate since 2019-12-03 Loss -11.94% PDF
Can-Fite BioPharma Ltd fell by -4.87% in the last day ( Friday, 13th Dec 2019 ) from $3.49 to $3.32 During the day the stock fluctuated 15.61% from a day low at $3.14 to a day high of $3.63. The price has fallen in 7 of the last 10 days and is down by -6.21% for this period. Volume has increased in the last day by 28 018 shares but on falling prices. This may be an early warning and the risk will be increased slightly for the next couple of days. In total, 113 957 shares bought and sold for approximately $378 337.00.
- 30 day high of the CANF stock price was $4.95 and low was $2.28.
- 90 day high was $4.95 and low was $1.90.
- 52 week high for Can-Fite BioPharma Ltd - $8.88 and low - $0.38.
Can-Fite BioPharma Ltd lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 40.49% during the next 3 months and, with 90% probability hold a price between $3.46 and $6.39 at the end of this period.
Can-Fite BioPharma Ltd holds a sales signal from the short-term moving average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock. On further gains, the stock will meet resistance from the short-term moving average at approximately $3.51. On a fall, the stock will find some support from the long-term average at approximately $2.80. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sales signal. A buy signal was issued from a pivot bottom point on Wednesday December 11, 2019, which indicates further gains until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. Can-Fite BioPharma Ltd gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".
Relative Strength Index (RSI)
RSImin/max Values: [ 25 - 75 ]
RSI14 is 58 and the stock is currently not being overbought or oversold
* Stockinvest.us uses dynamical calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behaviour.
Support & Resistance
On the downside, the stock finds support just below today's level from accumulated volume at $2.65 and $2.51.
There is natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Can-Fite BioPharma Ltd finds support just below today's level at $2.65. If this is broken, then the next support from accumulated volume will be at $2.51 and $2.50.
This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.49 between high and low, or 15.61%. For the last week, the stock has had a daily average volatility of 9.49%.
Our recommended stop-loss: $3.08 (-7.17%) (This stock has very high daily movements and this gives very high risk. There is a buy signal from pivot bottom found 2 days ago.)
9.49 %Average volatility
Very Low Low Medium High Very High
Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 8.000 stocks usually only a few will trigger a Golden Star Signal per day!